The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples